Condition
Malignant Mesothelioma|Metastatic Cancer
Estimated Enrollment: 270
Age Group: Child, Adult, Senior
Gender: All
Study Type: Observational
Study Design Allocation:
Study ID Numbers: CDR0000564050|INCA-RECF0433|INCA-05-145|INCA-Mesothel
Study First Received: May 9, 2009
Last Updated: December 13, 2009
Estimated Primary Completion Date: January 2010
Primary Outcome Measures:
Mesothelin and osteopontin concentrations in serum|Cytological, histological, immunohistochemical, and molecular markers of precancerous disease in tissue samples|Role of SV40|Relationship of serum concentration of mesothelin and/or osteopontin with the expression of other markers and with clinical progression
Sponsors and Collaborators:
University Hospital, Caen|National Cancer Institute (NCI)
Website Link: https://ClinicalTrials.gov/show/NCT00899613
